Schroder Investment Management Group’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-5,830
| Closed | -$216K | – | 1215 |
|
|
2023
Q4 | $216K | Sell |
5,830
-154
| -3% | -$5.53K | ﹤0.01% | 1147 |
|
|
2023
Q3 | $217K | Sell |
5,984
-17
| -0.3% | -$603 | ﹤0.01% | 1164 |
|
|
2023
Q2 | $214K | Buy |
+6,001
| New | +$215K | ﹤0.01% | 1187 |
|
|
2022
Q3 | – | Sell |
-5,350
| Closed | -$293K | – | 1300 |
|
|
2022
Q2 | $293K | Buy |
5,350
+294
| +6% | +$16.2K | ﹤0.01% | 1232 |
|
|
2022
Q1 | $277K | Buy |
5,056
+1,097
| +28% | +$59.6K | ﹤0.01% | 1277 |
|
|
2021
Q4 | $109K | Buy |
3,959
+164
| +4% | +$8.53K | ﹤0.01% | 1293 |
|
|
2021
Q3 | $90K | Buy |
3,795
+1,860
| +96% | +$93.4K | ﹤0.01% | 1408 |
|
|
2021
Q2 | $96K | Sell |
1,935
-1,930
| -50% | -$92.7K | ﹤0.01% | 1427 |
|
|
2021
Q1 | $173K | Hold |
3,865
| – | – | ﹤0.01% | 1336 |
|
|
2020
Q4 | $178K | Hold |
3,865
| – | – | ﹤0.01% | 1320 |
|
|
2020
Q3 | $181K | Hold |
3,865
| – | – | ﹤0.01% | 1192 |
|
|
2020
Q2 | $198K | Sell |
3,865
-224
| -5% | -$11.5K | ﹤0.01% | 1094 |
|
|
2020
Q1 | $194K | Hold |
4,089
| – | – | ﹤0.01% | 1110 |
|
|
2019
Q4 | $239K | Sell |
4,089
-299
| -7% | -$16.6K | ﹤0.01% | 1139 |
|
|
2019
Q3 | $232K | Buy |
4,388
+1,604
| +58% | +$82.5K | ﹤0.01% | 1139 |
|
|
2019
Q2 | $139K | Sell |
2,784
-400
| -13% | -$20.1K | ﹤0.01% | 1107 |
|
|
2019
Q1 | $166K | Sell |
3,184
-335
| -10% | -$16.7K | ﹤0.01% | 1077 |
|
|
2018
Q4 | $168 | Buy |
3,519
+11
| +0.3% | +$542 | ﹤0.01% | 1094 |
|
|
2018
Q3 | $177K | Buy |
3,508
+628
| +22% | +$31.9K | ﹤0.01% | 1144 |
|
|
2018
Q2 | $142K | Hold |
2,880
| – | – | ﹤0.01% | 1178 |
|
|
2018
Q1 | $141K | Hold |
2,880
| – | – | ﹤0.01% | 1182 |
|
|
2017
Q4 | $128K | Hold |
2,880
| – | – | ﹤0.01% | 1237 |
|
|
2017
Q3 | $145K | Hold |
2,880
| – | – | ﹤0.01% | 1224 |
|
|
2017
Q2 | $156K | Hold |
2,880
| – | – | ﹤0.01% | 1179 |
|
|
2017
Q1 | $153K | Hold |
2,880
| – | – | ﹤0.01% | 1131 |
|
|
2016
Q4 | $139K | Sell |
2,880
-246
| -8% | -$12.2K | ﹤0.01% | 1054 |
|
|
2016
Q3 | $168K | Sell |
3,126
-205
| -6% | -$11.2K | ﹤0.01% | 1042 |
|
|
2016
Q2 | $180K | Hold |
3,331
| – | – | ﹤0.01% | 1038 |
|
|
2016
Q1 | $170K | Buy |
3,331
+451
| +16% | +$22.5K | ﹤0.01% | 1031 |
|
|
2015
Q4 | $145K | Hold |
2,880
| – | – | ﹤0.01% | 1054 |
|
|
2015
Q3 | $138K | Hold |
2,880
| – | – | ﹤0.01% | 1047 |
|
|
2015
Q2 | $151K | Hold |
2,880
| – | – | ﹤0.01% | 1056 |
|
|
2015
Q1 | $169K | Hold |
2,880
| – | – | ﹤0.01% | 1079 |
|
|
2014
Q4 | $154K | Hold |
2,880
| – | – | ﹤0.01% | 1141 |
|
|
2014
Q3 | $165K | Sell |
2,880
-1,440
| -33% | -$88.3K | ﹤0.01% | 1183 |
|
|
2014
Q2 | $289K | Sell |
4,320
-4,000
| -48% | -$271K | ﹤0.01% | 1111 |
|
|
2014
Q1 | $556K | Buy |
8,320
+1,440
| +21% | +$97.3K | ﹤0.01% | 1044 |
|
|
2013
Q4 | $459K | Hold |
6,880
| – | – | ﹤0.01% | 1132 |
|
|
2013
Q3 | $431K | Buy |
+6,880
| New | +$443K | ﹤0.01% | 1128 |
|
Other funds holding GSK
JEST
Schroder Investment Management Group's GSK Position: Q1 2024 in Review
Schroder Investment Management Group sold out of GSK (GSK) in Q1 2024, closing a stake of 5,830 shares — an estimated $216K sold.
Schroder Investment Management Group first reported a position in GSK in Q3 2013 and held it in 39 quarters. The position peaked at $556K in Q1 2014. 910 funds tracked by Wall St. Rank hold GSK as of Q1 2024.
- Schroder Investment Management Group reported no remaining GSK position as of Q1 2024 after selling out during the quarter.
- Schroder Investment Management Group sold 5,830 GSK shares in Q1 2024, an estimated $216K.
- Schroder Investment Management Group first reported a position in GSK in Q3 2013 and held it in 39 quarters.
- Schroder Investment Management Group's GSK position peaked at $556K in Q1 2014.
- 910 funds tracked by Wall St. Rank held GSK as of Q1 2024.
Based on Schroder Investment Management Group's 13F filing for Q1 2024, filed 14 May 2024.